(lp0
S"Why NewLink Genetics Shares Are Crashing 33% Today Motley Fool - May 10, 2016 What: After NewLink Genetics Corporation  reported that its pancreatic cancer treatment algenpantucel-L failed to outperform standard of care, its shares lost a third of their value at 12:00 p.m.NewLink Genetics Announces Results from Phase 3 IMPRESS Trial of Algenpantucel ... - GlobeNewswire What's Next For NewLink - Seeking Alpha"
p1
aS'NewLink Genetics to Participate in 2017 SunTrust Orphan Drug Day on February 14th GlobeNewswire  - Feb 13, 2017 AMES, Iowa, Feb. 13, 2017  -- NewLink Genetics Corporation , a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today announced that it will participate in the&nbsp;...'
p2
aS"Why NewLink Genetics Corporation Shares Crashed Motley Fool - May 12, 2015 What: Shares in NewLink Genetics Corporation  collapsed by more than 25% earlier today after the company reported disappointing trial news for its pancreatic cancer drug, algenpantucel-L.NewLink Genetics' IMPRESS Phase 3 Pancreatic Cancer Trial with Algenpantucel-L ... - GlobeNewswire NewLink Genetics'  Phase 3 IMPRESS Trial to Continue - StreetInsider.com"
p3
aS'NewLink Genetics Has Many Near-Term Catalysts Seeking Alpha - Sep 27, 2016 NewLink Genetics  is a small biopharmaceutical company  developing novel immuno-oncology product candidates.'
p4
aS'Why NewLink Genetics Corporation Dropped 27.6% in May The motley Fool  - Jun 10, 2016 What: Shares of NewLink Genetics Corporation , a biopharmaceutical company developing immuno-oncology therapies, sank 27.6% last month, according to data from S&amp;P Global Market Intelligence.'
p5
aS'NewLink Genetics Corporation  Breaks into New 52-Week High on March 13 ... Equities.com - Mar 13, 2017 Shares of NewLink Genetics Corporation  broke into a new 52-week high yesterday, hitting a peak of $22.11. Shares closed at $21.95 after opening at $21.46 for a move of 2.57%.NewLink Genetics Corp  Climbing Higher 7.53% - Business ReviewStock Returns: NewLink Genetics Corporation  is Beating Myriad ... - CML News'
p6
aS'NewLink Genetics Provides Operational &amp; Clinical Update, Reports Fourth ... GlobeNewswire  - Feb 28, 2017 AMES, Iowa, Feb. 28, 2017  -- NewLink Genetics Corporation , a biopharmaceutical company focused on bringing novel immuno-oncology therapies to patients with cancer, today reported consolidated financial results&nbsp;...NewLink Genetics Corporation  Moves Higher on Volume Spike for February 28 - Equities.comNewLink Genetics Corporation  Files An 8-K Results of Operations ... - Market Exclusive'
p7
aS'NewLink Genetics: A Classic Value Catalyst Buy Seeking Alpha - Dec 29, 2016 Current information hints that IDO inhibitors have an important role to play in oncology and NewLink Genetics should be given more credit for its pipeline.'
p8
aS'NewLink Genetics to Host Its Fourth Quarter and Year End 2016 Financial ... GlobeNewswire  - Feb 20, 2017 AMES, Iowa, Feb. 20, 2017  -- NewLink Genetics Corporation , today reported that it will release its fourth quarter and year end 2016 financial results on Tuesday, February 28, 2017.NewLink Genetics : Moving Average Crossover Alert - NasdaqNewLink Genetics Corporation  Receives $23.67 Average Price Target from ... - The Cerbat Gem'
p9
aS'Unnoticed By The Street, Roche Updated NewLink Genetics IDO Partnership At ESMO Seeking Alpha - Nov 17, 2016 Roche declares on NLNK IDO &quot;We are taking it forward&quot; and outlines plan to extend IDO inhibition &quot;to a broader class of tumors&quot;.'
p10
a.